$ITOX
IIOT-OXYS, Inc.

2023 Q3 Form 10-Q Financial Statement

#000168316823005909 Filed on August 18, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $19.71K $35.29K
YoY Change -14.3% 113.87%
Cost Of Revenue $4.871K $8.495K
YoY Change -5.23% 1565.69%
Gross Profit $14.84K $26.79K
YoY Change -16.91% 67.57%
Gross Profit Margin 75.29% 75.93%
Selling, General & Admin $89.80K $117.7K
YoY Change -43.46% -45.9%
% of Gross Profit 605.0% 439.43%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $17.02K $12.34K
YoY Change 36.49% 0.0%
% of Gross Profit 114.67% 46.06%
Operating Expenses $102.3K $130.1K
YoY Change -40.29% -43.43%
Operating Profit -$87.43K -$103.3K
YoY Change -43.02% -51.73%
Interest Expense $88.48K $14.00K
YoY Change 493.29% -14.23%
% of Operating Profit
Other Income/Expense, Net $42.14K -$163.5K
YoY Change -62.08% -743.62%
Pretax Income -$45.29K -$266.8K
YoY Change 7.08% 41.46%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$45.29K -$266.8K
YoY Change 7.08% 41.46%
Net Earnings / Revenue -229.74% -755.93%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 406.8M shares 401.9M shares
Diluted Shares Outstanding 406.8M shares 405.3M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $17.79K $7.900K
YoY Change -48.1% -89.25%
Cash & Equivalents $17.79K $7.896K
Short-Term Investments
Other Short-Term Assets $17.80K $12.76K
YoY Change 129.09% 64.22%
Inventory
Prepaid Expenses
Receivables $10.92K $25.35K
Other Receivables $0.00 $0.00
Total Short-Term Assets $46.51K $46.01K
YoY Change -20.41% -57.81%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $409.7K $421.2K
YoY Change -10.05% -9.8%
TOTAL ASSETS
Total Short-Term Assets $46.51K $46.01K
Total Long-Term Assets $409.7K $421.2K
Total Assets $456.2K $467.2K
YoY Change -11.22% -18.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $95.30K $215.0K
YoY Change -40.28% 37.1%
Accrued Expenses $513.9K $469.0K
YoY Change 56.89% 56.12%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $359.3K $310.0K
YoY Change -1.07% -24.84%
Total Short-Term Liabilities $2.005M $1.977M
YoY Change 30.82% 17.67%
LONG-TERM LIABILITIES
Long-Term Debt $75.00K $124.3K
YoY Change -28.09% 126.0%
Other Long-Term Liabilities $1.000K $1.000K
YoY Change 0.0% 0.0%
Total Long-Term Liabilities $76.00K $125.3K
YoY Change -27.83% 123.75%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.005M $1.977M
Total Long-Term Liabilities $76.00K $125.3K
Total Liabilities $2.081M $2.102M
YoY Change 27.05% 21.09%
SHAREHOLDERS EQUITY
Retained Earnings -$9.831M -$9.768M
YoY Change 9.17% 9.07%
Common Stock $406.8K $406.8K
YoY Change 31.62% 44.88%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.244M -$2.180M
YoY Change
Total Liabilities & Shareholders Equity $456.2K $467.2K
YoY Change -11.22% -18.89%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$45.29K -$266.8K
YoY Change 7.08% 41.46%
Depreciation, Depletion And Amortization $17.02K $12.34K
YoY Change 36.49% 0.0%
Cash From Operating Activities -$49.42K -$17.26K
YoY Change -60.38% -90.9%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00 $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 63.87K 0.000
YoY Change -25.32% -100.0%
NET CHANGE
Cash From Operating Activities -49.42K -17.26K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 63.87K 0.000
Net Change In Cash 14.45K -17.26K
YoY Change -136.84% -85.1%
FREE CASH FLOW
Cash From Operating Activities -$49.42K -$17.26K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001290658
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-50773
dei Entity Registrant Name
EntityRegistrantName
IIOT-OXYS, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
56-2415252
dei Entity Address Address Line1
EntityAddressAddressLine1
705 Cambridge Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Cambridge
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02141
dei City Area Code
CityAreaCode
(401)
dei Local Phone Number
LocalPhoneNumber
307-3092
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
406815293 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7896 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33336 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
25353 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
28941 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12760 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7773 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
46009 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
70050 usd
CY2023Q2 ITOX Originall Issuance Discount On Note Receivable
OriginallIssuanceDiscountOnNoteReceivable
2856 usd
CY2022Q4 ITOX Originall Issuance Discount On Note Receivable
OriginallIssuanceDiscountOnNoteReceivable
4716 usd
CY2023Q2 ITOX Note Receivable Net
NoteReceivableNet
197144 usd
CY2022Q4 ITOX Note Receivable Net
NoteReceivableNet
195284 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
224038 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
248585 usd
CY2023Q2 us-gaap Assets
Assets
467191 usd
CY2022Q4 us-gaap Assets
Assets
513919 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
214967 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
133408 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
469032 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
395714 usd
CY2023Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
31425 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
31425 usd
CY2023Q2 ITOX Unearned Interests
UnearnedInterests
2219 usd
CY2022Q4 ITOX Unearned Interests
UnearnedInterests
5151 usd
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
310000 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
363167 usd
CY2023Q2 ITOX Shares Payable To Related Parties
SharesPayableToRelatedParties
17629 usd
CY2022Q4 ITOX Shares Payable To Related Parties
SharesPayableToRelatedParties
14624 usd
CY2023Q2 ITOX Salaries Payable To Related Parties
SalariesPayableToRelatedParties
305183 usd
CY2022Q4 ITOX Salaries Payable To Related Parties
SalariesPayableToRelatedParties
263516 usd
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
626563 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
469873 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1977018 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1676878 usd
CY2023Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
124300 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
104300 usd
CY2023Q2 ITOX Due To Stockholders
DueToStockholders
1000 usd
CY2022Q4 ITOX Due To Stockholders
DueToStockholders
1000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
2102318 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1782178 usd
CY2023Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
544800 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
544800 usd
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
26 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
26 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
406815293 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
406815293 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
352174583 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
352174583 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
406816 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
352175 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7181596 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7141877 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9768365 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9307137 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-2179927 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1813059 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
467191 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
513919 usd
CY2023Q2 us-gaap Revenues
Revenues
35289 usd
CY2022Q2 us-gaap Revenues
Revenues
16500 usd
us-gaap Revenues
Revenues
78572 usd
us-gaap Revenues
Revenues
16500 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
8495 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
510 usd
us-gaap Cost Of Revenue
CostOfRevenue
25459 usd
us-gaap Cost Of Revenue
CostOfRevenue
510 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
26794 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
15990 usd
us-gaap Gross Profit
GrossProfit
53113 usd
us-gaap Gross Profit
GrossProfit
15990 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
117739 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
217621 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
283938 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
384630 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
12341 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
12341 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
24547 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
24547 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
130080 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
229962 usd
us-gaap Operating Expenses
OperatingExpenses
308485 usd
us-gaap Operating Expenses
OperatingExpenses
409177 usd
CY2023Q2 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-155398 usd
CY2022Q2 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
36057 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-156690 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
151856 usd
CY2023Q2 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
0 usd
CY2022Q2 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
0 usd
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
0 usd
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
-201943 usd
CY2023Q2 us-gaap Interest Income Other
InterestIncomeOther
5921 usd
CY2022Q2 us-gaap Interest Income Other
InterestIncomeOther
5661 usd
us-gaap Interest Income Other
InterestIncomeOther
11777 usd
us-gaap Interest Income Other
InterestIncomeOther
5661 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
13996 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
16319 usd
us-gaap Interest Expense
InterestExpense
28524 usd
us-gaap Interest Expense
InterestExpense
263691 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-163473 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
25399 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-173437 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-308117 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-266759 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-188573 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-428809 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-701304 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-266759 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-188573 usd
us-gaap Net Income Loss
NetIncomeLoss
-428809 usd
us-gaap Net Income Loss
NetIncomeLoss
-701304 usd
CY2023Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
16299 usd
CY2022Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
12280 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
32419 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
24708 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-283058 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-200853 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-461228 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-726012 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
405346758 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
405346758 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
256513245 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
256513245 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
389868003 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
389868003 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
240541359 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
240541359 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1904293 usd
CY2023Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
7424 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-283058 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-2179927 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1813059 usd
ITOX Common Stock Issued For Financing Commitment
CommonStockIssuedForFinancingCommitment
54195 usd
ITOX Sales Commissions Paid On Capital Raise
SalesCommissionsPaidOnCapitalRaise
-1084 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
825 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
40425 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-461228 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-2179927 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1734713 usd
CY2022Q2 ITOX Common Stock Issued For Financing Commitment
CommonStockIssuedForFinancingCommitment
279539 usd
CY2022Q2 ITOX Sales Commissions Paid On Capital Raise
SalesCommissionsPaidOnCapitalRaise
-5590 usd
CY2022Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
90000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-200853 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1571617 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1264853 usd
ITOX Common Stock Issued For Financing Commitment
CommonStockIssuedForFinancingCommitment
393365 usd
ITOX Sales Commissions Paid On Capital Raise
SalesCommissionsPaidOnCapitalRaise
-7867 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
900 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
90000 usd
ITOX Beneficial Conversion Feature Associated With Discounts
BeneficialConversionFeatureAssociatedWithDiscounts
-57150 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-726012 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1571617 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-461228 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-726012 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
825 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
900 usd
ITOX Discount On Notes Receivable
DiscountOnNotesReceivable
-1860 usd
ITOX Discount On Notes Receivable
DiscountOnNotesReceivable
6606 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
37400 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
24547 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
24547 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3588 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
16500 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4987 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-0 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
81559 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4371 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
80574 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
53280 usd
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
156690 usd
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
241591 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-2932 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
15233 usd
ITOX Increase Decrease In Shares Payable To Related Parties
IncreaseDecreaseInSharesPayableToRelatedParties
3006 usd
ITOX Increase Decrease In Shares Payable To Related Parties
IncreaseDecreaseInSharesPayableToRelatedParties
8604 usd
ITOX Increase Decrease In Salaries Payable To Related Parties
IncreaseDecreaseInSalariesPayableToRelatedParties
41667 usd
ITOX Increase Decrease In Salaries Payable To Related Parties
IncreaseDecreaseInSalariesPayableToRelatedParties
11899 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-78551 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-346823 usd
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
-0 usd
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
200000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-200000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
54195 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
393365 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1084 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
7867 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
188000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
53111 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
573498 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-25440 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
26675 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33336 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46821 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7896 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
73496 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
ITOX Conversion Of Convertible Notes Payable And Derivative Liabilities
ConversionOfConvertibleNotesPayableAndDerivativeLiabilities
40425 usd
ITOX Conversion Of Convertible Notes Payable And Derivative Liabilities
ConversionOfConvertibleNotesPayableAndDerivativeLiabilities
0 usd
ITOX Effect Of Adopting Asu202006
EffectOfAdoptingAsu202006
0 usd
ITOX Effect Of Adopting Asu202006
EffectOfAdoptingAsu202006
57149 usd
CY2023Q2 ITOX Working Capital
WorkingCapital
-1931009 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-78551 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9768365 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
24953 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
49500 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84A_eus-gaap--UseOfEstimates_zI7ipZkNaenc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration: underline"><span id="xdx_861_zcRKSwwrTywl">Use of Estimates</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the valuation of accounts payable, accrued liabilities and payable to related parties. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
49500 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
49500 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
224038 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
248585 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
495000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
495000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
270962 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
246415 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
224038 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
248585 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
12341 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
12341 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
24547 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
24547 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
49500 usd
CY2023Q2 ITOX Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
1085 usd
CY2023Q2 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
224038 usd
CY2023Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
510000 usd
CY2022Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
543167 usd
CY2023Q2 ITOX Deferred Financing Costs
DeferredFinancingCosts
-75700 usd
CY2022Q4 ITOX Deferred Financing Costs
DeferredFinancingCosts
-75700 usd
CY2023Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
0 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
0 usd
CY2023Q2 ITOX Convertible Notes Payable Net
ConvertibleNotesPayableNet
434300 usd
CY2022Q4 ITOX Convertible Notes Payable Net
ConvertibleNotesPayableNet
467467 usd
CY2023Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
310000 usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
363167 usd
CY2023Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
124300 usd
CY2022Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
104300 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-283058 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-200853 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-461228 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-726012 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
405346758 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
405346758 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
256513245 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
256513245 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
389868003 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
389868003 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
240541359 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
240541359 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
422388170 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
362428633 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
406815293 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
406815293 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
352174583 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
352174583 shares
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
626563 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
469873 usd
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0 shares
CY2021Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
2868397 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.00084
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P2Y4M24D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0
CY2022Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2868397 shares
CY2022Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.00084
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P2Y
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0 shares
CY2022Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
2868397 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.00084
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P1Y4M24D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0
CY2023Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2868397 shares
CY2023Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.00084
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P1Y

Files In Submission

Name View Source Status
0001683168-23-005909-index-headers.html Edgar Link pending
0001683168-23-005909-index.html Edgar Link pending
0001683168-23-005909.txt Edgar Link pending
0001683168-23-005909-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
iiot_ex1001.htm Edgar Link pending
iiot_ex3101.htm Edgar Link pending
iiot_ex3102.htm Edgar Link pending
iiot_ex3201.htm Edgar Link pending
iiot_ex3202.htm Edgar Link pending
iiot_i10q-063023.htm Edgar Link pending
itox-20230630.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
itox-20230630_cal.xml Edgar Link unprocessable
itox-20230630_def.xml Edgar Link unprocessable
itox-20230630_lab.xml Edgar Link unprocessable
itox-20230630_pre.xml Edgar Link unprocessable
iiot_i10q-063023_htm.xml Edgar Link completed
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending